Light chain myeloma plasma cells induce a strong cell-mediated immune response mainly directed against the monoclonal light chain determinants in a murine experimental model

Cancer Immunology, Immunotherapy

Volumn 51, Issue 4, 2002, Pages 229-234

  Galea, Horia Radu ^a   Denizot, Yves ^a   Cogné, Michel ^a  

^a LIMOGES UNIVERSITY HOSPITAL   (France)

Author keywords

Myeloma; Plasma cell; Secreted tumor antigen; Vaccination

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN LIGHT CHAIN; MITOMYCIN C; PARAPROTEIN; TUMOR ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CANCER SURVIVAL; CELL DIVISION; CELL SUSPENSION; CELLULAR IMMUNITY; CONTROLLED STUDY; EXPERIMENTAL MODEL; FEMALE; IMMUNIZATION; MALIGNANT NEOPLASTIC DISEASE; MOUSE; MYELOMA; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, NEOPLASM; CYTOTOXICITY TESTS, IMMUNOLOGIC; FEMALE; IMMUNIZATION; IMMUNOGLOBULIN LIGHT CHAINS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MULTIPLE MYELOMA; PLASMA CELLS; T-LYMPHOCYTES;

EID: 0036257460     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-002-0274-6     Document Type: Article

References (21)

1. Monoclonal Ig L chain and L chain V domain fragment crystallization in myeloma-associated Fanconi's syndrome
2. Idiotypic vaccination in B-cell malignancies
3. Towards development of T-cell vaccines
4. The role of B7-1/B7-2: CD28/CTLA-4 pathways in the prevention of anergy, induction of protective immunity and down-regulation of the immune response
5. Induction of syngeneic cytotoxic T lymphocytes against a B cell tumor. I. Role of idiotypic immunoglobulin
6. Induction of syngeneic cytotoxic T lymphocytes against a B cell tumor. II. Characterization of anti-idiotypic CTL lines and clones
7. Mutational analysis in murine models for myeloma-associated Fanconi's syndrome or cast myeloma nephropathy
8. + T cell expansions are found preferentially in patients with a low tumor burden
9. Tumor-specific idiotypes vaccines in the treatment of patients with B-cell lymphoma - Long-term results of a clinical trial
10. Role of light chain variable region in myeloma with light chain deposition disease: Evidence from an experimental model
11. Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumor
12. Myeloma proteins as tumor-specific transplantation antigens
13. Idiotype vaccination in human myeloma: Generation of tumor-specific immune responses after high-dose chemotherapy
14. Immunoregulatory mechanisms in multiple myeloma
15. NK cell receptor calibration: Effect of MHC class I induction on killing by Ly49A high and Ly49A low NK cells
16. Cancer vaccines
17. A better cell line for making hybridomas secreting specific antibodies
18. Immunotherapeutic strategies for the treatment of plasma cell malignancies
19. Treatment of multiple myeloma by antibody-mediated immunotherapy and induction of myeloma selective antigens
20. Cytotoxic T lymphocyte clone recognizing self idiotype: Its regulatory role in antibody production
21. Idiotype-reactive T-cell subsets and tumor load in monoclonal gammopathies